ACADIA PHARMACEUTICALS INC. - Weekly - Technical analysis published on 08/24/2020 (GMT)
- 315
- 0
- Who voted?
Click here for a new analysis!
- Timeframe : Weekly
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Additional analysis
Quotes
ACADIA PHARMACEUTICALS INC. rating 38.00 USD. Over 5 days, this instrument lost -3.70% with the lowest point at 37.93 USD and the highest point at 40.09 USD. The deviation from the price is +0.18% for the low point and -5.21% for the high point.The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of this Weekly chart of ACADIA PHARMACEUTICALS INC. indicates that the overall trend is not clearly defined. The strong bearish signals currently being given by short-term moving averages could allow the overall trend to return to a bearish trend. The Central Indicators scanner detects bearish signals on moving averages that could impact this trend:
Bearish trend reversal : Moving Average 20
Type : Bearish
Timeframe : Weekly
Bearish price crossover with adaptative moving average 100
Type : Bearish
Timeframe : Weekly
In fact, 11 technical indicators on 18 studied are currently positioned bearish. But beware of excesses. The Central Indicators scanner currently detects this:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : Weekly
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : Weekly
MACD indicator is back under 0
Type : Bearish
Timeframe : Weekly
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows a result that can have an impact on the price change:
Support of channel is broken
Type : Bearish
Timeframe : Weekly
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 17.26 | 22.57 | 30.20 | 38.00 | 39.49 | 45.88 | 50.10 |
Change (%) | -54.58% | -40.61% | -20.53% | - | +3.92% | +20.74% | +31.84% |
Change | -20.74 | -15.43 | -7.80 | - | +1.49 | +7.88 | +12.10 |
Level | Intermediate | Minor | Major | - | Major | Major | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 36.34 | 37.13 | 37.73 | 38.52 | 39.12 | 39.91 | 40.51 |
Camarilla | 37.94 | 38.07 | 38.19 | 38.32 | 38.45 | 38.58 | 38.70 |
Woodie | 36.24 | 37.08 | 37.63 | 38.47 | 39.02 | 39.86 | 40.41 |
Fibonacci | 37.13 | 37.66 | 37.99 | 38.52 | 39.05 | 39.38 | 39.91 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 35.09 | 36.48 | 37.40 | 38.79 | 39.71 | 41.10 | 42.02 |
Camarilla | 37.69 | 37.90 | 38.11 | 38.32 | 38.53 | 38.74 | 38.96 |
Woodie | 34.86 | 36.36 | 37.17 | 38.67 | 39.48 | 40.98 | 41.79 |
Fibonacci | 36.48 | 37.36 | 37.91 | 38.79 | 39.67 | 40.22 | 41.10 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 17.45 | 29.14 | 35.35 | 47.04 | 53.25 | 64.94 | 71.15 |
Camarilla | 36.65 | 38.29 | 39.93 | 41.57 | 43.21 | 44.85 | 46.49 |
Woodie | 14.72 | 27.77 | 32.62 | 45.67 | 50.52 | 63.57 | 68.42 |
Fibonacci | 29.14 | 35.97 | 40.20 | 47.04 | 53.87 | 58.10 | 64.94 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 41.55 | |
MACD (12,26,9): | -0.7700 | |
Directional Movement: | -8.40 | |
AROON (14): | -42.86 | |
DEMA (21): | 44.55 | |
Parabolic SAR (0,02-0,02-0,2): | 54.50 | |
Elder Ray (13): | -5.48 | |
Super Trend (3,10): | 37.61 | |
Zig ZAG (10): | 38.29 | |
VORTEX (21): | 0.9900 | |
Stochastique (14,3,5): | 1.58 | |
TEMA (21): | 41.78 | |
Williams %R (14): | -98.82 | |
Chande Momentum Oscillator (20): | -7.53 | |
Repulse (5,40,3): | -17.4400 | |
ROCnROLL: | 2 | |
TRIX (15,9): | 0.3400 | |
Courbe Coppock: | 21.41 |
MA7: | 39.01 | |
MA20: | 41.01 | |
MA50: | 46.80 | |
MA100: | 47.31 | |
MAexp7: | 41.84 | |
MAexp20: | 44.64 | |
MAexp50: | 42.17 | |
MAexp100: | 37.37 | |
Price / MA7: | -2.59% | |
Price / MA20: | -7.34% | |
Price / MA50: | -18.80% | |
Price / MA100: | -19.68% | |
Price / MAexp7: | -9.18% | |
Price / MAexp20: | -14.87% | |
Price / MAexp50: | -9.89% | |
Price / MAexp100: | +1.69% |
News
The latest news and videos published on ACADIA PHARMACEUTICALS INC. at the time of the analysis were as follows:
- ACADIA Pharmaceuticals to Present at The JMP Securities CNS Forum on August 19, 2020
- ACADIA Pharmaceuticals Reports Second Quarter 2020 Financial Results
- People with Dementia and Caregivers Share the Significant Burden of Visual Hallucinations and Paranoid Delusions, New Survey Highlights
- ACADIA Pharmaceuticals to Announce Second Quarter 2020 Financial Results on August 5, 2020
- ACADIA Pharmaceuticals Announces U.S. FDA Accepted for Filing the Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
Add a comment
Comments
0 comments on the analysis ACADIA PHARMACEUTICALS INC. - Weekly